| abstract |
Compounds having the formula (I)n npharmaceutical compositions containing them and their methods of use for the treatment of neurological disorders related to amyloid β protein production and neurological disorders such as Alzheimer's disease.. These compounds inhibit γ secretase and thereby inhibit the production of amyloid P protein, thereby acting to prevent the formation of neurological deposits of amyloid protein. |